½ÃÀ庸°í¼­
»óǰÄÚµå
1424419

¼¼°èÀÇ Ãµ°ñ½Å°æ ÀÚ±Ø ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Global Sacral Nerve Stimulation Market, By Product Type, By Application, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Ãµ°ñ½Å°æ ÀÚ±Ø ½ÃÀå ±Ô¸ð´Â 2023³â 4¾ï 2,270¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â 6¾ï 3,410¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ Áß ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 6%¸¦ ³ªÅ¸³À´Ï´Ù.

¸®Æ÷Æ® ´ë»ó ¹üÀ§ ¸®Æ÷Æ® »ó¼¼
±âÁسâ 2022³â 2023/2024³â ½ÃÀå ±Ô¸ð 4¾ï 2,270¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2018-2021³â ¿¹Ãø ±â°£ 2023-2030
¿¹Ãø ±â°£ 2023³â/2024-2030³â/2031³â CAGR : 6.00% 2030/2031³âÀÇ ¿¹ÃøÄ¡ 6¾ï 3,410¸¸ ´Þ·¯
µµÇ¥ 1. ¼¼°èÀÇ Ãµ°ñ½Å°æ ÀÚ±Ø ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2023³â
Global Sacral Nerve Stimulation Market-IMG1

õ°ñ½Å°æ ÀÚ±Ø(SNS)Àº ¹æ±¤, Àå, °ñ¹ÝÀú Àå¾Ö¸¦ Ä¡·áÇϱâ À§ÇØ À̽ÄÇü ½Å°æÀڱرâ·Î ºÒ¸®´Â ¼ÒÇü ÀÇ·á±â±â¸¦ ¼³Ä¡ÇÏ´Â Àúħ½À¼ö¼úÀÔ´Ï´Ù.

õ°ñ ½Å°æ ÀÚ±Ø ½Ã½ºÅÛ¿¡´Â ŸÀÌ´× ¸®µå ½Ã½ºÅÛ°ú ÆÐµé ¸®µå ½Ã½ºÅÛÀÇ µÎ °¡Áö À¯ÇüÀÌ ÀÖ½À´Ï´Ù. ƾµå ¸®µå ½Ã½ºÅÛ¿¡¼­´Â ¿µ»ó À¯µµ ÇÏ¿¡¼­ ¸®µå(lead)¶ó°í ºÒ¸®´Â ÀÛÀº Àü±ØÀÌ ´Þ¸° °¡´À´Ù¶õ ¿ÍÀ̾ ÇǺθ¦ ÅëÇØ S3 õ°ñ°ø ºÎÀ§¿¡ »ðÀÔÇÕ´Ï´Ù. ±× ÈÄ, ¸®µå´Â ³»ÀåµÈ ÆÞ½º ¹ß»ý±â¿¡ ºÎÂøµÇ¾î ¾ûµ¢ÀÌ ÇϺο¡ »ðÀԵ˴ϴÙ. ÆÐµé ¸®µå ½Ã½ºÅÛÀº ³¡¿¡ ÆòÆòÇÏ°í ºÎµå·¯¿î ÆÐµéÀÌ ´Þ¸° ¸®µå¸¦ ¼ö¼ú·Î õ°ñ ½Å°æ¿¡ Á÷Á¢ ºÎÂøÇÏ´Â ¹æ½ÄÀÔ´Ï´Ù.

µÎ ½Ã½ºÅÛ ¸ðµÎ Àå°ú ¹æ±¤ÀÇ ±â´ÉÀ» ´ã´çÇϴ õ°ñ ½Å°æ¿¡ °¡º­¿î Àü±â ÆÞ½º¸¦ º¸³»´Â ¹æ½ÄÀ¸·Î ÀÛµ¿ÇÕ´Ï´Ù. À̸¦ ÅëÇØ Áõ»óÀÇ ¿øÀÎÀÌ µÇ´Â ºñÁ¤»óÀûÀÎ ½ÅÈ£¸¦ Â÷´ÜÇϰí Á¤»óÀûÀÎ ±â´ÉÀ» ȸº¹ÇÏ´Â °ÍÀÔ´Ï´Ù. õ°ñ½Å°æÀڱؼúÀº °ú¹Î¼º ¹æ±¤, º¯½Ç±Ý, ¸¸¼º °ñ¹ÝÅë µîÀÇ Áõ»ó °³¼±¿¡ Å« È¿°ú¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÀåÁ¡À¸·Î´Â ÃÖ¼Òħ½ÀÀûÀ̶ó´Â Á¡, ÄÑ°í ²ø ¼ö ÀÖ´Â Á¶Àý °¡´ÉÇÑ Ä¡·á¹ýÀ̶ó´Â Á¡, ÄÑ°í ¸çÄ¥ ¸¸¿¡ È¿°ú¸¦ º¼ ¼ö ÀÖ´Ù´Â Á¡ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÓÇöõÆ®´Â ¿µ±¸ÀûÀÎ ¼ö¼úÀÌ ÇÊ¿äÇϸç, °á±¹ ¹èÅ͸® ±³Ã¼ ¼ö¼úÀÌ ÇÊ¿äÇÏ´Ù´Â ´ÜÁ¡ÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸®µå°¡ Àå±âÀûÀ¸·Î ÃÖÀûÀÇ À§Ä¡¿¡¼­ ¹þ¾î³¯ °¡´É¼ºµµ ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ : .

¼¼°èÀÇ Ãµ°ñ½Å°æ ÀÚ±Ø ½ÃÀåÀº ÁÖ·Î ¸¸¼ºÀûÀÎ µð¹ÙÀ̽ºÀÇ º¸±Þ¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¸é 2018³â 12¿ù¿¡ ±¹¸³»ý¹°Á¤º¸¼¾ÅÍ(NCBI)°¡ ¹ßÇ¥ÇÑ µ¥ÀÌÅÍ¿¡ µû¸£¸é ¼¼°èÀÇ ¸¸¼º ÅëÁõ À¯º´·ü Á¶»ç¿¡¼­´Â ÀεµÀÇ ¼ºÀÎ Àα¸ 19.3%°¡ ³ú¼º¸¶ºñ¿¡ ±«·Î¿öÇϰí ÀÖ´Â °ÍÀ» ¾Ë¾Ò½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ¼¼°èÀÇ Ãµ°ñ½Å°æ ÀÚ±Ø ½ÃÀåÀ» »ó¼¼È÷ ºÐ¼®Çϰí, 2022³âÀ» ±âÁسâÀ¸·Î ÇÑ ¿¹Ãø ±â°£(2023-2030³â)ÀÇ ½ÃÀå ±Ô¸ð ¹× ¿¬Æò±Õ ¼ºÀå·ü(CAGR %)À» Á¦°øÇÕ´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¸ÅÃâ ±âȸ¸¦ ¼³¸íÇϰí, ÀÌ ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¿¡ ´ëÇØ ÇØ¼³Çϰí ÀÖ½À´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ ÀλçÀÌÆ®µµ Á¦°øÇϰí ÀÖ½À´Ï´Ù.
  • ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ½ÇÀû, Àü·« µîÀÇ ÆÄ¶ó¹ÌÅÍ¿¡ ±â¹ÝÇÏ¿© ¼¼°èÀÇ Ãµ°ñ½Å°æ ÀÚ±Ø ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇϰí ÀÖ½À´Ï´Ù.
  • ÀÌ ¸®Æ÷Æ®·ÎºÎÅÍÀÇ ÀλçÀÌÆ®´Â ¸¶ÄÉÆÃ ´ã´çÀÚ ¹× ±â¾÷ÀÇ °æ¿µÁøÀÌ ÇâÈÄ Á¦Ç°ÀÇ ¹ß¸Å, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ °üÇÑ Á¤º¸¿¡ ±â¹ÝÇÑ ÀÇ»ç°áÁ¤À» ½ÃÇàÇÏ´Â °ÍÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù.
  • ¼¼°èÀÇ Ãµ°ñ½Å°æ ÀÚ±Ø ½ÃÀå ¸®Æ÷Æ®´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü¿©¾÷ü, À繫 ¾Ö³Î¸®½ºÆ® µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¿¡°Ô ´ëÀÀÇϰí ÀÖ½À´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚ´Â ¼¼°èÀÇ Ãµ°ñ½Å°æ ÀÚ±Ø ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • ¸®Æ÷Æ® ¼³¸í
    • ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
  • ÃËÁø¿äÀÎ
    • °í·ÉÀÚ Àα¸ÀÇ Áõ°¡
    • ¿ä½Ç±ÝÀÇ À¯º´·ü Áõ°¡
  • ¾ïÁ¦¿äÀÎ
    • õ°ñ½Å°æ ÀڱرâÀÇ °íºñ¿ë
  • ±âȸ
    • »õ·Î¿î ÀÚ±Ø ½Ã½ºÅÛÀÇ °³¹ß
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • ÃÖ±Ù µ¿Çâ
  • PEST ºÐ¼®
  • PorterÀÇ »ê¾÷ ºÐ¼®
  • ÇÕº´, Àμö ¹× Çù¾÷

Á¦4Àå ¼¼°èÀÇ Ãµ°ñ½Å°æ ÀÚ±Ø ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿ªÇÐ
  • °ø±ÞÃø°ú ¼ö¿äÃø ºÐ¼®
  • °æÁ¦Àû ¿µÇâ

Á¦5Àå ¼¼°èÀÇ Ãµ°ñ½Å°æ ÀÚ±Ø ½ÃÀå, Á¦Ç° À¯Çüº°, 2018-2030³â

  • »ðÀÔÇü SNS µð¹ÙÀ̽º
  • ¿ÜºÎ SNS µð¹ÙÀ̽º
  • ¾×¼¼¼­¸®

Á¦6Àå ¼¼°èÀÇ Ãµ°ñ½Å°æ ÀÚ±Ø ½ÃÀå, ¿ëµµº°, 2018-2030³â

  • ¿ä½Ç±Ý°ú º¯½Ç±Ý
  • ¸¸¼º ÅëÁõ
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ Ãµ°ñ½Å°æ ÀÚ±Ø ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2018-2030³â

  • º´¿ø
  • Ŭ¸®´Ð
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ

Á¦8Àå ¼¼°èÀÇ Ãµ°ñ½Å°æ ÀÚ±Ø ½ÃÀå, Áö¿ªº°, 2018-2030³â

  • ºÏ¹Ì
  • ¹Ì±¹
  • ij³ª´Ù
  • À¯·´
  • µ¶ÀÏ
  • ¿µ±¹
  • ½ºÆäÀÎ
  • ÇÁ¶û½º
  • ÀÌÅ»¸®¾Æ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áß±¹
  • Àεµ
  • ÀϺ»
  • È£ÁÖ
  • Çѱ¹
  • ASEAN
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • ºê¶óÁú
  • ¾Æ¸£ÇîÆ¼³ª
  • ¸ß½ÃÄÚ
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
  • GCC ±¹°¡
  • À̽º¶ó¿¤
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
  • ºÏ¾ÆÇÁ¸®Ä«
  • Áß¾Ó¾ÆÇÁ¸®Ä«
  • ³²¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • ±â¾÷ °³¿ä
    • Medtronic plc.
    • Boston Scientific Corporation
    • Nevro Corp
    • StimWave Technologies Inc
    • Axonics
    • Synapse Biomedical
    • Uroplasty
    • Jude Medical
    • Cogentix Medical
    • Others

Á¦10Àå ¼½¼Ç

  • Âü°í ¹®Çå
  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç ¼Ò°³
KSA 24.02.27

Global sacral nerve stimulation market size is expected to reach US$ 634.1 Mn by 2030, from US$ 422.7 Mn in 2023, exhibiting a compound annual growth rate (CAGR) of 6% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023/2024: US$ 422.7 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR: 6.00% 2030/2031 Value Projection: US$ 634.1 Mn
Figure 1. Global Sacral Nerve Stimulation Market Share (%), By Region, 2023
Global Sacral Nerve Stimulation Market - IMG1

Sacral nerve stimulation (SNS) is a minimally invasive procedure that involves placing a small medical device called an implantable neurostimulator to treat bladder, bowel, and pelvic floor disorders.

There are two types of sacral nerve stimulation systems - tined lead and paddle lead systems. Tined lead systems involve the insertion of a thin wire with tiny electrodes at the tip, called a lead, through the skin into the S3 sacral foramen area under imaging guidance. The lead is then attached to an internal pulse generator which is implanted in the lower butt area. Paddle lead systems involve surgically placing a lead with a flat, soft paddle at its tip which sits directly on the sacral nerve.

Both systems work by sending mild electrical pulses to the sacral nerves that control bowel and bladder function. This disrupts the abnormal signals causing symptoms and restores normal function. Sacral nerve stimulation has shown significant success in improving symptoms of overactive bladder, fecal incontinence, and chronic pelvic pain. Some advantages include being minimally invasive, with a adjustable therapy that can be turned on or off, byproviding improvements within days of being turned on. However, the implants do require permanent surgical placement and eventual battery replacement surgery. There is also a chance of leads moving out of optimal position long-term.

Market Dynamics:

Global sacral nerve stimulation market is mainly driven by the increasing prevalence of chronic devices. For instance, according to the data published by the National Center for Biotechnology Information (NCBI) in December 2018, the global chronic pain prevalence survey found that 19.3% Indian adult population suffers from cerebral palsy.

Key features of the study:

  • This report provides in-depth analysis of the global sacral nerve stimulation market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global sacral nerve stimulation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Medtronic plc., Boston Scientific Corporation, Nevro Corp, StimWave Technologies Inc., Axonics, Inc., Synapse Biomedical, Uroplasty, St. Jude Medical, Cogentix Medical, and Others
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global sacral nerve stimulation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dacral nerve stimulation market

Detailed Segmentation:

  • Global Sacral Nerve Stimulation Market, By Product Type
    • Implantable SNS Devices
    • External SNS Devices
    • Accessories
  • Global Sacral Nerve Stimulation Market, By Application
    • Urinary and Fecal Incontinence
    • Chronic Pain
    • Others
  • Global Sacral Nerve Stimulation Market, By End User
    • Hospital
    • Clinics
    • Ambulatory Surgery Centers
  • Global Sacral Nerve Stimulation Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Top Companies in the Global Sacral Nerve Stimulation Market:
    • Medtronic plc.
    • Boston Scientific Corporation
    • Nevro Corp
    • StimWave Technologies Inc.
    • Axonics, Inc.
    • Synapse Biomedical
    • Uroplasty
    • Jude Medical
    • Cogentix Medical
    • Others

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Drivers
    • Increasing geriatric population
    • Increasing prevalence of urinary incontinence
  • Restraint
    • High cost of sacral nerve stimulation devices
  • Opportunity
    • Development of new stimulation systems
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Sacral Nerve Stimulation Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Sacral Nerve Stimulation Market, By Product Type, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Implantable SNS Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • External SNS Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Accessories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Global Sacral Nerve Stimulation Market, By Application, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Urinary and Fecal Incontinence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Chronic Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

7. Global Sacral Nerve Stimulation Market, By End User, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Ambulatory Surgery Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

8. Global Sacral Nerve Stimulation Market, By Region, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profile
    • Medtronic plc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Boston Scientific Corporation
    • Nevro Corp
    • StimWave Technologies Inc
    • Axonics
    • Synapse Biomedical
    • Uroplasty
    • Jude Medical
    • Cogentix Medical
    • Others
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦